The genetic diversity and phenotypic characterisation of streptococcus agalactiae isolates from Rio de Janeiro, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 8, 2011, Pages 1002-1006

  de Almeida Corrêa, Ana Beatriz ^a   da Silva, Lígia Guedes ^a   de Castro Abreu Pinto, Tatiana ^a   de Oliveira, Ivi Cristina Menezes ^a   Fernandes, Flávio Gimenis ^a   da Costa, Natalia Silva ^a   de Mattos, Marcos Corrêa ^a   Fracalanzza, Sergio Eduardo Longo ^a   Benchetrit, Leslie Claude ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antimicrobial susceptibility; Polymerase chain reaction; Pulsed field gel electrophoresis; Streptococcus agalactiae

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; ERMA PROTEIN, BACTERIA; MEFA PROTEIN, STREPTOCOCCUS; MEMBRANE PROTEIN; METHYLTRANSFERASE;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; PHENOTYPE; PREGNANCY; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARRIER STATE; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PREGNANCY; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS AGALACTIAE;

EID: 84855494604     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000800017     Document Type: Article

References (33)

1. Benchetrit LC, Fracalanzza SEL, Peregrino H, Camelo AA, Sanches LALR 1982. Carriage of Streptococcus agalactiae in women and neonates and distribution of serological types: a study in Brazil. J Clin Microbiol 15: 787-790.
2. Betriu C, Culebras E, Gómez M, Rodríguez-Avial I, Sánchez BA, Agreda MC, Picazo JJ 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother 47: 1112-1114.
3. Bozdogan B, Berrezouga L, Kuo MS, Yurek DA, Farley KA, Stockman BJ, Leclercq LA 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob Agents Chemother 43: 925-929.
4. CDC - Centers for Disease Control and Prevention 2002. Prevention of perinatal group B streptococcal diseases: revised guidelines from CDC. MMWR CDC Surveill summ (Atlanta GA) 51: 11.
5. CLSI - Clinical and Laboratory Standards Institute 2006. Performance standards for antimicrobial susceptibility testing: 16th informational supplement, M100-S16 26, CLSI, Wayne, p. 138-140.
6. Corrêa ABA, Oliveira ICM, Pinto T de CA, Mattos MC, Benchetrit LC 2009. Pulsed-field gel electrophoresis, virulence determinants and antimicrobial susceptibility profiles of type Ia group B streptococci isolated from humans in Brazil. Mem Inst Oswaldo Cruz 104: 599-603.
7. De Azavedo JCS, McGavin M, Duncan C, Low DE, McGeer A 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolated from Ontario, Canada. Antimicrob Agents Chemother 45: 3504-3508.
8. De Mouy D, Cavallo JD, Leclercq R, Fabre R, AFIRCORP-BIO network 2001.Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother 45: 2400-2402.
9. Duarte RS, Bellei BC, Miranda OP, Brito MAVP, Teixeira LM 2005. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agents Chemother 49: 97-103.
10. Faccone D, Lalonardi F, Abel S, Machain M, Errecalde L, Littvik A, Kauffman S, Galas M, WHONET-Argentina Group, Corso A 2010. Multiple-clones of Streptococcus agalactiae harbouring lnuB gene. J Infect Dev Ctries 4: 580-582.
11. Ferjani A, Ben Abdallah H, Ben Saida N, Gozzi C, Boukadida J 2006. Vaginal colonization of the Streptococcus agalactiae in pregnant woman in Tunisia: risk factors and susceptibility of isolates to antibiotics. Bull Soc Pathol Exot 99: 99-102.
12. Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, Orefici G, Dicuonzo G, Creti R 2007. Molecular epidemiology and distribution of serotypes, surface proteins and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol 45: 2909-2916.
13. Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME 2007. Detection of erythromycin and clindamycin resistance genes in group B streptococcal clinical isolates and cervicovaginal-rectal swabs. Microb Drug Resist 13: 119-123.
14. Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N, Nagano N, Kato H, Shibayama K, Arakawa Y 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52: 2890-2897.
15. Lancefield RC, Freimer EH 1966. Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond) 64: 191-203.
16. Llaneza E, Seral C, Castillo FJ, Durán E, Rubio-Calvo C, Gómez-Lus R 2009. Characterization of clinical blood isolates of Streptococcus agalactiae with reduced susceptibility to levofloxacin. J Chemother 21: 463-464.
17. Martins ER, Pessanha MA, Ramirez M, Melo-Cristino J, Portuguese group for the study of streptococcal infections 2007. Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol 45: 3224-3229.
18. Mee-Marquet N, Jouannet C, Domelier AS, Arnault L, Lartigue MF, Quentin R 2009. Genetic diversity of Streptococcus agalactiae strains and density of vaginal carriage. Med Microbiol 58: 169-173.
19. Mollerach A, Méndez E, Massa R, di Conza J 2007. Streptococcus agalactiae isolated in Santa Fe, Argentina: antibiotic susceptibility and erythromycin-clindamycin resistance mechanisms. Enferm Infecc Microbiol Clin 25: 67-68.
20. Nakamura PAM, Schuab RBB, Neves FPG, Pereira CFA, de Paula GR, Barros RR 2011. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae. Mem Inst Oswaldo Cruz 106: 119-122.
21. Oliveira ICM, de Mattos MC, Areal MFT, Ferreira-Carvalho BT, Figueiredo AMS, Benchetrit LC 2005. Pulsed-field gel electrophoresis of human group B streptococci isolated in Brazil. J Chemother 17: 258-263.
22. Palmeiro JK, Dalla-Costa LM, Fracalanzza SE, Botelho AC, da Silva Nogueira K, Scheffer MC, de Almeida Torres RS, de Carvalho NS, Cogo LL, Madeira HM 2010. Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. J Clin Microbiol 48: 4397-4403.
23. Pinheiro S, Radhouani H, Coelho C, Gonçalves A, Carvalho E, Carvalho JA, Ruiz-Larrea F, Torres C, Igrejas G, Poeta P 2009. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Microb Drug Resist 15: 121-124.
24. Sambrook J, Fritsh EF, Maniatis T 1989. Molecular cloning: a laboratory manual, Cold Spring Harbor Laboratory Press, New York, 1659 pp.
25. Savoia D, Gottimer C, Crocilla C, Zucca M 2008. Streptococcus agalactiae in pregnant women: phenotypic and genotypic characters. J Infect 56: 120-125.
26. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342: 15-20.
27. Seppälä H, Nissinen A, Yo Q, Huovinen P 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32: 885-891.
28. Singh A, Goering RV, Simjee S, Foley SL, Zervos MJ 2006. Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev 19: 512-530.
29. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL 2007. Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 45: 2929-2936.
30. Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, Talbot JA 2000. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study - 1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis 182: 168-173.
31. Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, Flores AE, Ferrieri P, Baker CJ 2000. Invasive disease due group B streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 30: 276-281.
32. Zeng X, Kong F, Wang H, Darbar A, Gilbert GL 2006. Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob Agents Chemother 50: 204-209.
33. Zhao Z, Kong F, Zeng X, Gidding HF, Morgan J, Gilbert GL 2008. Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups. Clin Microbiol Infect 14: 260-267.